THE INFLUENCE OF THE CARDIOPULMONARY BYPASS PRIMEON METABOLISM DURING CARDIOPULMONARY BYPASS
DOI:
https://doi.org/10.32782/2411-9164.19.1-5Keywords:
Cardiosurgery, cardiopulmonary bypass,prime, perioperative energy monitoring, metabolismAbstract
Objective. To assess the possibility of using personalized energy monitoring during cardiopulmonary bypass, improving perioperative metabolism during cardiopulmonary bypass due to optimization of cardiopulmonary bypass primesolution. Materials and methods. The study included 25 patientswho underwent coronaryartery bypass grafting with cardiopulmonary bypass. In group 1 the prime included a4% succinylated gelatin solution, 15% Mannitol, 4.2%Soda-Bufer, Reosorbilact, heparin. In group 2 the prime included a 4% succinylated gelatin solution, 15% mannitol, 4% sodium bicarbonate, 0.9% sodium chloride and heparin. Results. The results of the studyshowed that the cardiac surgery patientsinitiallyhavevaryingdegrees of metabolicdisorders. In the group 1 where Soda-Bufer 4.2% and Reosorbilact were used, the parameters of the MetabolicRateIndexwere closer to theTargetMetabolicRateIndex and more exceeded the BasalMetabolicRateIndexthan in the group 2. Conclusion. Cardiac surgery patients belong to the risk group for metabolic disorders. Perioperative energy monitoring allowsto controlthe Metabolic Rate Index. One of the ways to improve perioperative metabolism is the use of 4.2%Soda-Bufer and Reosorbilact as prime components.
References
Boytsova O.N. Jenergostrukturnyj status priperioperacionnoj sedoanalgezii. Aktual’nі pitannja farmacevtichnoi і medichnoi nauki ta praktiki. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky. 2018 Trav-Serp; 11(2): 197–203. URL: http://nbuv.gov.ua/UJRN/apfimntp_2018_11_2_14.
Smirnova L.M. Biojenergeticheskaja nedostatochnost’ anesteziologicheskogo obespechenija. Bil, zneboliuvannia i intensyvnaterapiia. 2016 Luit 28; 4(77): 59–65. URL: https://doi.org/10.25284/2519-2078.4(77).2016.94332.
Pattullo S.J, Samson D.M. Adult cardiopulmonary bypass in Australian and New Zealand public hospitals: A survey of practice. Anaesth Intensive Care. 2020 Nov; 48(6):465-472. doi: 10.1177/0310057X20960730. Epub 2020 Nov 19. PMID: 33210548.
Wildhirt S.M. Patient-centered cardiopulmonary bypass concepts. Heart Surg Forum. 2009 Jun;12(3): E168-74. doi: 10.1532/HSF98.20091049. PMID: 19546071.
Sobanska L.O, Cherniy V.I, vynakhidnyky; Derzhavna naukova ustanova «Naukovo-praktychnyi tsentr profilaktychnoi ta klinichnoi medytsyny» Derzhavnoho upravlinnia spravamy, patentovlasnyk. Sklad rozchyniv dlia zapovnennia pervynnoho obiemuoksyhenatora. P atent Ukrainy № 140427. 2020 Luit 25. [In Ukrainian].
Chernii V.I., Denysenko A.I. Suchasni mozhlyvosti vykorystannia nepriamoi kalorymetrii u pisliaoperatsiinomuenerho monitorynhu. Klinichna ta profilaktychna medytsyna 2020 Trav 28; 2(12): 79–89. [In Ukrainian]. URL: https://doi.org/10.31612/2616-4868.2(12).2020.05.
Cherniy V.I, Denysenko A.I. Kontsentratsiia kortizolukrovi, hemodynamika ta metabolizm patsiientiv z vtorynnym hiperparatyreozom, mozhlyvosti peryoperatsiinoi korektsii. Bil, znebolennia ta intensyvna terapiia. 2021 Veres 30; 3(96): 54–63. [In Ukrainian]. URL: https://doi.org/10.25284/2519-2078.3(96).2021.242148.
Cherniy V.I, Kuznecova I.V, Momot N.V et all. Principy i metody korrekcii metabolicheskogo acidoza, voznikajushhego vovremja reperfuzii pri operacijah na serdce s iskusstvennym krovoobrashheniem. Ukrain. zhurn. jekstremal’noj mediciny im. G.A. Mozhaeva. 2007; 3: 48–55.
Avakov V.E, Sajipov R.M, Davydov D.V, Begmatov SZh, Bazarov A.N. Detoksicirujushhie svojstva preparata. Reosorbilakt i ego vlijanie na gemostaz. Medicina neotlozhnyh sostojanij, 2014; 2 (57): 47–51.